Viatris VTRS
NASDAQ VTRS
$16.44 -0.17 (-1.02%)
As of: Sep 9, 2026 · 1:47 PM EDT

Viatris (VTRS) Research & Development (2020 - 2026)

Viatris (VTRS) posted Research & Development of $248.3 million for Q2 2026, little changed on a QoQ basis from $248.6 million in Q1 2026, and up 13.48% year-over-year from $218.8 million in Q2 2025.

Analysis

Viatris (VTRS) Research & Development (2020 - 2026) Analysis & Trends

Viatris has reported Research & Development for 7 years, with the latest figure at $248.3 million in Q2 2026.

  • On a quarterly basis, Research & Development rose 13.48% year-over-year to $248.3 million in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 20.85% increase from a year earlier, with the FY2025 full-year figure at $965.9 million, up 19.44% from the prior year.
  • Research & Development was $248.3 million for Q2 2026 at Viatris, roughly flat from $248.6 million in the prior quarter.
  • The five-year high for Research & Development was $274.7 million in Q4 2025, with the low at $142.3 million in Q1 2022.
  • Average Research & Development over 5 years is $207.7 million, with a median of $205.3 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2025: Research & Development declined 22.71% in 2022, then surged 33.03% in 2025.
  • Over 5 years, Research & Development stood at $182.4 million in 2022, then gained by 11.18% to $202.8 million in 2023, then grew by 1.82% to $206.5 million in 2024, then soared by 33.03% to $274.7 million in 2025, then decreased by 9.61% to $248.3 million in 2026.
  • The last three Research & Development figures came in at $248.3 million (Q2 2026), $248.6 million (Q1 2026), and $274.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 42.60 Bn 38.95 Bn 2.15 Bn 970.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 248.30 Mn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 60.90 Mn
4 Amneal Pharmaceuticals 5.46 Bn 5.33 Bn 334.51 Mn 39.02 Mn
5 Bausch Health Companies 2.36 Bn 520.75 Mn 2.10 Bn 173.00 Mn
6 Alvotech 1.51 Bn 1.37 Bn 2.56 Mn -21.86 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 14.75 Mn
8 Amphastar Pharmaceuticals 992.90 Mn 702.78 Mn 93.47 Mn 22.16 Mn
9 Fennec Pharmaceuticals 411.09 Mn 369.84 Mn 17.15 Mn 10.66 Mn
10 RedHill Biopharma 181.39 Mn 181.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 248.30 Mn
Mar 31, 2026 248.60 Mn
Dec 31, 2025 274.70 Mn
Sep 30, 2025 250.40 Mn
Jun 30, 2025 218.80 Mn
Mar 31, 2025 222.00 Mn
Dec 31, 2024 206.50 Mn
Sep 30, 2024 198.40 Mn
Jun 30, 2024 204.10 Mn
Mar 31, 2024 199.70 Mn
Dec 31, 2023 202.80 Mn
Sep 30, 2023 211.20 Mn
Jun 30, 2023 208.30 Mn
Mar 31, 2023 182.90 Mn
Dec 31, 2022 182.40 Mn
Sep 30, 2022 174.90 Mn
Jun 30, 2022 162.60 Mn
Mar 31, 2022 142.30 Mn
Dec 31, 2021 197.10 Mn
Sep 30, 2021 152.10 Mn